References

  1. Ghadouane M, Zannoud M, Alami M, Albouzidi A, Labraimi A, Safi L et al. Tumeur neuroendocrine à petites cellules de la vessie: une nouvelle observation. Ann Urol. 2003 Apr;37(2):75-8. PubMed | Google Scholar

  2. Navarra S, Pfister C, Gobet F, Cappele O, Planet M, Grise P. Tumeur neuroendocrine maligne de vessie : une entité à ne pas méconnaître. Prog Urol. 1999 Feb;9(1):129-32. PubMed | Google Scholar

  3. Chekrine T, De Bari B, Cassier P, Kulisa M, Chapet O, Mornex F. Carcinome neuroendocrine à petites cellules de la vessie : à propos d’une observation et revue de littérature. Cancer Radiother. 2011 Jun;15(3):250-3. PubMed | Google Scholar

  4. Vincendeau S, de Lajarte-Thirouard A-S, Bensalah K, Guille F, Lobel B, Patard J-J. Différenciation neuro-endocrine des tumeurs de vessie. Prog Urol. 2003 Jun;13(3):375-84. PubMed | Google Scholar

  5. Choong NWW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder - The Mayo Clinic experience. Cancer. 2005 Mar 15;103(6):1172-8. PubMed | Google Scholar

  6. Elktaibi A, Nasri A, Oukabli M, Bernoussi Z, Bouzidi AA, Mahassini N. Carcinome neuroendocrine à petites cellules de la vessie : une entité anatomoclinique rare et agressive. J Afr Cancer Afr J Cancer. 2013;5:237-9. PubMed | Google Scholar

  7. Bellmunt J, Orsola A, Wiegel T, Guix M, De Santis M, Kataja V, et al. Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011 Sep;22 Suppl 6:vi45-9. PubMed | Google Scholar

  8. Ismaili N, Heudel PE, Elkarak F, Kaikani W, Bajard A, Ismaili M et al. Out-come of recurrent and metastatic small cell carcinoma of the bladder. BMC Urol. 2009;9:4. PubMed | Google Scholar

  9. Cheng L, Pan C-X, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H et al. Small cellcarcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer. 2004 Sep 1;101(5):957-62. PubMed | Google Scholar

  10. Sved P, Gomez P, Manoharan M, Civantos F, Soloway MS. Small cell carcinoma of the bladder. BJU Int. 2004 Jul;94(1):12-7. PubMed | Google Scholar

  11. Siefker-Radtke AO, Kamat AM, Grossman HB, Williams DL, Qiao W, Thall PF et al. Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. J Clin Oncol. 2009 Jun 1;27(16):2592-7. PubMed | Google Scholar

  12. Lynch SP, Shen Y, Kamat A, Grossman HB, Shah JB, Millikan RE et al. Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the M D Anderson Cancer Center. Eur Urol. 2013;64:307-13. PubMed | Google Scholar

  13. Bex A, Nieuwenhuijzen JA, Kerst M, Pos F, van Boven H, Meinhardt W, et al.Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology. 2005 Feb;65(2):295-9. PubMed | Google Scholar

  14. Macedo LT, Ribeiro J, Curigliano G, Fumagalli L, Locatelli M, Carvalheira JBC et al. Multidisciplinary approach in the treatment of patients with small cellbladder carcinoma. Eur J Surg Oncol. 2011 Jul;37(7):558-62. PubMed | Google Scholar